Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism Nav1.7 modulators(Sodium channel protein type IX alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Encoded Therapeutics, Inc.Startup |
Active Organization Encoded Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | US | Encoded Therapeutics, Inc.Startup | 31 Aug 2024 |